Streetbeat News

Earnings

CSTL

Castle Bioscience projects its FY24 revenue to be between $235 million and $240 million, compared to its previous year's revenue of $214.693 million.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:14 pm

LPSN

LivePerson (NASDAQ:LPSN) reported Q4 2023 earnings with a GAAP EPS of $(0.48), missing the $(0.31) estimate, but sales of $95.47M exceeded the $94.13M forecast. This represents a 12.73% decrease in losses per share compared to last year, but a 22.05% drop in sales from the same period.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:12 pm

WW

WW International Inc. (NASDAQ:WW) reported Q4 adjusted losses per share of $1.11 and sales of $206 million, missing estimates slightly. Oprah Winfrey will not seek re-election to the board but plans to continue advocating for health equity and obesity awareness. She will donate her WW stock to the National Museum of African American History and Culture. WW shares fell 22.15% after-hours to $2.97.

Portfolio Pulse from Erica Kollmann

February 28, 2024 | 10:12 pm

CTKB

Cytek Biosciences reported Q4 sales of $58.60M, surpassing the $56.58M estimate, marking a 21.25% increase from last year's $48.34M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:11 pm

SVC

Service Properties Trust (NASDAQ:SVC) reported Q4 2023 FFO of $0.31 per share, missing the $0.36 estimate, and sales of $444.05M, beating the $427.11M estimate. This represents a decrease in earnings and sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:10 pm

STN

Stantec (NYSE:STN) reported Q4 sales of $912.70M, surpassing the analyst consensus estimate of $908.67M by 0.44% and marking an 8.45% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:09 pm

STN

Stantec has revised its 2024 financial targets, increasing its net revenue growth expectations from 7%-12% to 11%-15% and adjusting its EPS growth targets from 11%-16% to 12%-16%.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:07 pm

GEF

Greif (NYSE:GEF) reported Q1 2024 adjusted EPS of $1.27, surpassing the $0.47 estimate by 170.21%, but its sales of $1.21B fell short of the $1.28B estimate by 5.52% and decreased 5.11% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:05 pm

STKL

SunOpta (NASDAQ:STKL) reported Q4 2023 adjusted EPS of $0.05, surpassing the $0.02 estimate, with sales of $181.62M exceeding the $170.79M forecast. This represents a 17.93% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:03 pm

STN

Stantec (NYSE:STN) reported its Q4 adjusted earnings per share (EPS) at $0.60, missing the consensus estimate of $0.64 by 5.78%. This represents a 1.15% decrease from the $0.61 EPS reported in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 10:03 pm